Follow the BALAXI PHARMACEUTICALS LIMITED stock price and the full management transaction log of the company, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, BALAXI PHARMACEUTICALS LIMITED has logged 15 reports. Market capitalisation: €1.4bn. The latest transaction was filed on 12 April 2024 (Purchase). Among the most active insiders: KUNAL MAHENDRA BHAKTA. All data is free.
15
Insider Decl.
0
Thresholds
€1m
9 ops.
Buy Volume
€789,566
6 ops.
Sell Volume
18Σ signal
Buys €1m€789,566 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 21,324 of 26,132 companies
29.5
score / 100
Value
25
Quality
35
FCF yld-35%
Earn yld1.1%
EV/EBITDA16.8x
ROE0.6%
Gross mgn44%
Net mgn0.5%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.